EVALUATION OF LIVER FUNCTIONAL RESERVE IN CIRRHOSIS BY USING OF 13C-METHACETIN RESPIRATORY TEST
https://doi.org/10.16931/1995-5464.2017119-24
Abstract
Non-invasive methods are increasingly used in recent years to assess liver functional reserve. The widespread application of 13C-methacetin respiratory test in clinical practice promises to improve the assessment of liver functional reserve and to specify prognosis in liver cirrhosis patients. Features of 13C-methacetin respiratory test application are presented.
About the Authors
I. G. Bakulin
Mechnikov Northwestern State Medical University
Russian Federation
Doct. of Med. Sci., Professor, Head of the Department of Propaedeutics of Internal Medicine, Gastroenterology and Nutrition
Russian Federation
Doct. of Med. Sci., Professor, Head of the Department of Propaedeutics of Internal Medicine, Gastroenterology and Nutrition
Yu. V. Medvedev
Mechnikov Northwestern State Medical University
Russian Federation
Postgraduate Student of the Department of Propaedeutics Internal Medicine, Gastroenterology and Nutrition
Russian Federation
Postgraduate Student of the Department of Propaedeutics Internal Medicine, Gastroenterology and Nutrition
References
1. Sadovnikova I.I. Liver cirrhosis. Questions of etiology, pathogenesis, clinical manifestations, diagnosis, treatment. Russkiy meditsinskiy zhurnal. 2003; 2: 37. (In Russian)
2. Gunnarsdottir S.A., Olsson R., Olafsson S., Cariglia N., Westin J., Thjodleifsson B., Björnsson E. Liver cirrhosis in Iceland and Sweden: incidence, etiology and outcomes. Scand. J. Gastroenter. 2009; 44 (8): 984–993. DOI: 10.1080/00365520902912571.
3. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepat. 2015; 63 (1): 237–264. PMID: 25911335. DOI: 10.1016/j.jhep.2015.04.006.
4. Bakulin I.G., Sandler Y.G., Keyan V.A., Rotin D.L. A new noninvasive method of steatosis evaluating in chronic liver diseases. Terapevticheskiy arkhiv. 2016; 88 (2): 49–57. DOI: 10.17116/terarkh201688249-57. (In Russian)
5. Arroyo V., Gines P., Abraldes, J.G. Treatment of liver diseases. Barcelona: Ars Medica, 2009. 526 p.
6. Sidorov D.V., Rubtsova N.A., Leontyev A.V., Lozhkyn M.V., Petrov L.O., Lazutina T.N., Pylova I.V., Korolev P.A., Isaeva A.G. Methods for liver functional state assessment in the planning of anatomic resections for primary and metastatic tumors: state of the art, own experience and perspectives. Issledovaniya i praktika v meditsine. 2015; 2 (1): 13–20. DOI: 10.17709/2409-2231-2015-2-1-13-20. (In Russian)
7. Musialik J., Jonderko K., Kasicka-Jonderko A., Buschhaus M. 13CO2 breath tests in non-invasive hepatological diagnosis. Przegląd Gastroenterologiczny. 2015; 10 (1): 1–6. DOI: 10.5114/pg.2014.47501. PMCID: PMC4411407.
8. Pijls K.E., de Vries H., Nikkessen S., Bast A., Wodzig W.K., Koek G.H. Critical appraisal of 13C breath tests for microsomal liver function: aminopyrine revisited. Liver Internat. 2014; 34 (4): 487–494. DOI: 10.1111/liv.12451. PMID: 24428683.
9. Krumbiegel P., Günther K., Faust H., Möbius G., Hirschberg K., Schneider G. Nuclear medicine liver function tests for pregnant women and children. 1. Breath tests with 14C-methacetin and 13C-methacetin. J. Nucl. Med. 1985; 10 (3–4): 129–133. PMID: 3996441.
10. Modak A.S. An update on 13C-breath tests: The transition to acceptability into clinical practice. Volatile biomarkers: non-invasive diagnosis in physiology and medicine. Ed. by Amann A., Smith D. 1st edition. Elsevier, 2013. P. 245–265. DOI: 10.1016/B978-0-44-462613-4.00014-3.
11. Merkel C., Gatta A., Zoli M., Bolognesi M., Angeli P., Iervese T., Marchesini G., Ruol A. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig. Dis. Sci. 1991; 36 (9): 1197–1203.
12. Grishina V.G., Nevmerzhitskiy V.I., Senchenkov S.A. Study of liver metabolic function by using of carbon isotope respiratory test. http://pandia.ru/14929/ (In Russian)
13. Baruque S.L., Razquin M., Jimenez I., Vazquez A., Gisbert J.P., Pajares J.M. 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig. Liver Dis. 2000; 32 (3): 226–232. PMID: 10975773.
14. Petrolati A., Festi D., De Berardinis G., Colaiocco-Ferrante L., Di Paolo D., Tisone G., Angelico M. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Alimentary Pharmacol. Therapeutics. 2003; 18 (8): 785–790. PMID: 14535871.
15. Matsumoto K., Suehiro M., Ilo M., Kawabe T., Shiratori Y., Okano K., Sugimoto T. [13C]methacetin breath test for evaluation of liver damage. Dig. Dis. Sci. 1987; 32 (4): 344–348. PMID: 3030679.
16. Novruzbekov M.S., Donova L.V., Khodareva E.N., Androsova M.V., Zhao A.V., Nevmerzhitskiy V.I. Prognostic criteria of liver failure after liver resection for its focal lesion. Annaly khirurgicheskoy gepatologii. 2009; 14 (1): 41–48. (In Russian)
17. Pfaffenbach B., Götze O., Szymanski C., Hagemann D., Adamek, R. J. The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis. Deutsche Medizinische Wochenschrift. 1998; 123: 1467–1471. PMID: 9861887. DOI: 10.1055/s-2007-1024202.
18.
Review
For citations:
Bakulin I.G., Medvedev Yu.V. EVALUATION OF LIVER FUNCTIONAL RESERVE IN CIRRHOSIS BY USING OF 13C-METHACETIN RESPIRATORY TEST. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2017;22(1):19-24. (In Russ.) https://doi.org/10.16931/1995-5464.2017119-24
Views:
800
Email this article 